Oncotelic Therapeutics, Inc. (OTLC) Revenue 2021–2024
Oncotelic Therapeutics, Inc. (OTLC) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$70,000FY2024 · since FY2021: $1.7M → $70,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $70,000 | — |
| FY2021 | $1.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More OTLC financial trends
OTLC Net incomeOTLC Net marginOTLC Gross profitOTLC Gross marginOTLC Operating incomeOTLC Operating marginOTLC Operating cash flowOTLC Free cash flowOTLC Capital expendituresOTLC Return on equityOTLC Stock buybacksOTLC Dividends paidOTLC Total assetsOTLC Total liabilitiesOTLC Shareholders’ equityOTLC overview →